Rapid Microbiology Testing Market | Business Overview, Key Insights, Recent Developments

Growth in the Rapid Microbiology Testing Market can be attributed to factors such the rising prevalence of infectious diseases; ongoing technological advancements; increasing food safety concerns; and increased funding, research grants, and public-private investments. Emerging countries and a growing focus on the detection of antimicrobial resistance are expected to provide significant growth opportunities in the market.

What the Market Looks Like?

Predicted to grow at a CAGR of 8.1% during the forecast period, the Global Rapid Microbiology Testing Market is estimated to reach USD 5.09 billion by the end of 2023. In 2018, North America is expected to dominate the global market.

On the basis of product, the market is segmented into instruments, reagents & kits, and consumables. The instruments segment is further categorized into automated ID/AST systems, mass spectrometers, PCR systems, bioluminescence- and fluorescence-based detection systems, cytometers, active air samplers, and other instruments. The automated microbial ID/AST systems segment is expected to command the largest share of the global market in 2018. This is primarily due to the ability of these systems to produce rapid, accurate, reliable, and cost-effective results.

Based on method, the global market is classified into segments growth-based, viability-based, cellular component-based, nucleic acid-based, and other rapid microbiology testing methods. The growth-based segment is expected to account for the largest share of the Rapid Microbiology Testing Market in 2018. The large share of this segment can be attributed to factors such as the ease of processing (this method uses conventional liquid or agar media), the limited requirement of skilled professionals, and supportive government regulations.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=31548521

What Drives the Market?

The growth of the global market for Rapid Microbiology Testing is primarily influenced by the following factors:

• Rising Incidence of Infectious Diseases
• Technological Advancements
• Increasing Food Safety Concerns
• Funding, Research Grants, and Public-Private Investments
• Government Initiatives for the Detection of Antimicrobial Resistance

Geographical growth scenario of Rapid Microbiology Testing Market:

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global Rapid Microbiology Testing Market during the forecast period (2018–2023). The large share of this market can be attributed to the growing technological advancements in the field of rapid microbial testing, rising incidence of infectious diseases, and growing food safety concerns. In addition, the region has supportive government initiatives that help create awareness and promote the adoption of advanced microbial testing devices among key end users, thereby propelling the growth of the market in North America.

Leading market players and strategies adopted:

The prominent players in the Rapid Microbiology Testing Market include Biomérieux SA (France), Danaher Corporation (US), And Becton, Dickinson And Company (US), Abbott Laboratories Inc. (US), Bruker Corporation (US), Charles River Laboratories International, Inc. (US), Don Whitley Scientific Limited (UK), Merck Kgaa (Germany), Neogen (US), Quidel Corporation (US), Rapid Micro Biosystems, Inc. (US), Sartorius Group (Germany), Thermo Fisher Scientific (US).

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 com